Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trametinib and Panitumumab in Advanced Colorectal Cancer
NCT02399943Phase 2Completed
- Sponsor
- University Health Network
- Start
- Jun 2015
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of trametinib in colorectal cancer (CRC), sponsored by University Health Network. Primary endpoint: Percentage of patients who experience complete response, partial response, or stable disease at 24 weeks. Started Jun 2015; status: completed.
02
Drugs
trametinib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02399943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02399943.